References
- Macfarlane DG, Dieppe PA. Diuretic-induced gout in elderly women. Br J Rheumatol 1985;24(2): 155–7
- Fam AG. Gout in the elderly: clinical presentation and treatment. Drugs Aging 1998;13(3):229–43
- Emmerson BT. The management of gout. N Engl J Med 1996;334(7):445–51
- Emmerson BT. Abnormal urate excretion associated with renal and systemic disorders, drugs, and toxins. In: Kelley WN, Weiner IM, eds. Handbook of experimental pharmacology; vol 51: Uric acid. New York: Springer-Verlag, 1978:287–324
- Emmerson BT. Regimen of indomethacin therapy in acute gouty arthritis. Br Med J 1967;2(547):272–4
- Ritter J, Kerr LD, Valeriano-Marcet J, et al. ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems. J Rheumatol 1994;21(4):696–9
- Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. J Rheumatol 1994;21(7):1325–7
- Yü T. The efficacy of colchicine prophylaxis in articular gout: a reappraisal after 20 years. Semin Arthritis Rheum 1982;12(2):256–64
- Wallace AL, Singer JZ. Therapy in acute gout. Rheum Dis Clin North Am 1988; 14(2):441–57
- Thompson GR, Duff IF, Robinson WD, et al. Long term uricosuric therapy in gout. Arthritis Rheum 1962;5(Aug):384–96
- Coronary Drug Project Research Group. Serum uric acid: its association with other risk factors and with mortality in coronary heart disease. J Chronic Dis 1976;29(9):557–69
- Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study. Am J Med 1987;82(3):421–6
- Fessel WJ. Renal outcomes of gout and hyperuricemia. Am J Med 1979;67(1):74–82